Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats

Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia

(2011) Anand Gururajan et al.   BEHAVIOURAL BRAIN RESEARCH

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

(2011) Serena Deiana et al.   PSYCHOPHARMACOLOGY

Current pharmacological models of social withdrawal in rats

(2010) Anand Gururajan et al.   BEHAVIOURAL PHARMACOLOGY

A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

(2009) Leonora E. Long et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

(2009) Daniel Thomas Malone et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity

(2009) Anand Gururajan et al.   PHYSIOLOGY & BEHAVIOR

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Validation of a novel social investigation task that may dissociate social motivation from exploratory activity

(2008) Terrence Deak et al.   BEHAVIOURAL BRAIN RESEARCH

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆

(2008) D BOULAY et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism

(2007) Kazuhide Hayakawa et al.   BRAIN RESEARCH